KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Daily Values

Growth Metrics

Others

Medtronic (MDT) Current Deferred Revenue (2025)

Historic Current Deferred Revenue for Medtronic (MDT) over the last 1 years, with Q4 2025 value amounting to $318.0 million.

Medtronic's Current Deferred Revenue changed N/A to $318.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $318.0 million, marking a year-over-year change of. This contributed to the annual value of $391.0 million for FY2025, which is N/A changed from last year.
As of Q4 2025, Medtronic's Current Deferred Revenue stood at $318.0 million.
Medtronic's Current Deferred Revenue's 5-year high stood at $391.0 million during Q2 2025, with a 5-year trough of $318.0 million in Q4 2025.